Ian R. Marsh

740 total citations
31 papers, 304 citations indexed

About

Ian R. Marsh is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian R. Marsh has authored 31 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian R. Marsh's work include Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ian R. Marsh is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ian R. Marsh collaborates with scholars based in United States, United Kingdom and Sweden. Ian R. Marsh's co-authors include Mark Bradley, Bryan P. Bednarz, Joseph J. Grudzinski, Helen K. Smith, Jamey P. Weichert, Reinier Hernandez, Simon J. Teague, Eduardo Aluicio‐Sarduy, Jonathan W. Engle and Justin J. Jeffery and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Ian R. Marsh

28 papers receiving 289 citations

Peers

Ian R. Marsh
Andreea D. Stuparu United States
Shihong Li United States
Andrew F. Voter United States
R T Smith United States
Mary Ann Clements United States
Andreea D. Stuparu United States
Ian R. Marsh
Citations per year, relative to Ian R. Marsh Ian R. Marsh (= 1×) peers Andreea D. Stuparu

Countries citing papers authored by Ian R. Marsh

Since Specialization
Citations

This map shows the geographic impact of Ian R. Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Marsh more than expected).

Fields of papers citing papers by Ian R. Marsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Marsh. The network helps show where Ian R. Marsh may publish in the future.

Co-authorship network of co-authors of Ian R. Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Marsh. A scholar is included among the top collaborators of Ian R. Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Marsh. Ian R. Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Zachary S., Richard L. Wahl, Matthew S. Block, et al.. (2025). Interim safety and efficacy data of [ 212 Pb]VMT01 in MC1R expressing melanoma.. Journal of Clinical Oncology. 43(16_suppl). 3099–3099. 1 indexed citations
2.
Huang, Ellen, Reza Farjam, Ian R. Marsh, et al.. (2024). Commissioning and validation of a single photon beam model in RayStation for multiple matched Elekta Linacs. Journal of Applied Clinical Medical Physics. 25(10). e14485–e14485. 1 indexed citations
3.
Adam, David P., Joseph J. Grudzinski, Ian R. Marsh, et al.. (2024). Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 119(4). 1275–1284. 1 indexed citations
4.
Carlson, Peter M., Ravi B. Patel, Jen Birstler, et al.. (2023). Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. Journal for ImmunoTherapy of Cancer. 11(1). e005463–e005463. 9 indexed citations
5.
Marsh, Ian R., Chunrong Li, Joseph J. Grudzinski, et al.. (2023). Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry. Cancer Biotherapy and Radiopharmaceuticals. 38(7). 458–467. 1 indexed citations
6.
Potluri, Hemanth K., Carolina A. Ferreira, Joseph J. Grudzinski, et al.. (2022). Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors. Journal for ImmunoTherapy of Cancer. 10(8). e005060–e005060. 20 indexed citations
7.
Adam, David P., Joseph J. Grudzinski, Benjamin L. Cox, et al.. (2022). Validation of Monte Carlo 131I radiopharmaceutical dosimetry workflow using a 3D‐printed anthropomorphic head and neck phantom. Medical Physics. 49(8). 5491–5503. 7 indexed citations
8.
Marsh, Ian R., Michelle Turek, Joseph J. Grudzinski, et al.. (2021). Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PLoS ONE. 16(8). e0255798–e0255798. 20 indexed citations
9.
Brown, R. R., Reinier Hernandez, Joseph J. Grudzinski, et al.. (2019). Ability of Molecular Targeted Radionucleotide Therapy and Anti-CTLA-4 to Prevent Spontaneous Metastases in a Preclinical Lewis Lung Carcinoma Model. International Journal of Radiation Oncology*Biology*Physics. 105(1). E498–E499. 2 indexed citations
10.
Grudzinski, Joseph J., Reinier Hernandez, Ian R. Marsh, et al.. (2019). Preclinical Characterization of 86/90Y-NM600 in a Variety of Murine and Human Cancer Tumor Models. Journal of Nuclear Medicine. 60(11). 1622–1628. 19 indexed citations
11.
Marsh, Ian R., Joseph J. Grudzinski, Dana C. Baiu, et al.. (2019). Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models. Journal of Nuclear Medicine. 60(10). 1414–1420. 18 indexed citations
12.
Grudzinski, Joseph J., Ian R. Marsh, Justin J. Jeffery, et al.. (2018). CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 33(3). 87–95. 9 indexed citations
13.
Baiu, Dana C., Ian R. Marsh, Saswati Bhattacharya, et al.. (2017). Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog. Journal of Nuclear Medicine. 59(2). 244–250. 13 indexed citations
14.
Dack, Kevin N., S. Skerratt, Patrick S. Johnson, Paul A. Bradley, & Ian R. Marsh. (2010). Optimisation of a pyrazole series of progesterone antagonists; Part 1. Bioorganic & Medicinal Chemistry Letters. 20(11). 3384–3386. 3 indexed citations
15.
Marsh, Ian R., Björn Grönvall, & Martı́n Varela. (2006). A systematic study of PESQ’s behavior(from a networking perspective). 11 indexed citations
16.
Marsh, Ian R.. (2002). Easing the chemistry bottleneck: careers in high-throughput chemistry. Nature Reviews Drug Discovery. 1(11). 925–925. 4 indexed citations
17.
Marsh, Ian R. & Mark Bradley. (1997). Substrate Specificity of Trypanothione Reductase. European Journal of Biochemistry. 243(3). 690–694. 20 indexed citations
18.
Marsh, Ian R. & Mark Bradley. (1997). Solid phase synthesis of polyamine conjugates for the study of trypanothione reductase. Tetrahedron. 53(51). 17317–17334. 30 indexed citations
19.
Marsh, Ian R., Mark Bradley, & Simon J. Teague. (1997). Solid-Phase Total Synthesis of Oscillamide Y and Analogues. The Journal of Organic Chemistry. 62(18). 6199–6203. 24 indexed citations
20.
Marsh, Ian R., Helen K. Smith, Catherine Leblanc, & Mark Bradley. (1997). Synthetic methods for polyamine linkers and their application to combinatorial chemistry. Molecular Diversity. 2(3). 165–170. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026